Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Yonghe Medical Group Co., Ltd. ( (HK:2279) ) has shared an update.
Yonghe Medical Group reported a 4.3% decrease in revenue to RMB861.6 million for the first half of 2025, but saw a 3.9% increase in gross profit to RMB550.3 million and a significant improvement in net profit to RMB27.9 million from a net loss the previous year. The company’s EBITDA surged by 226.7% to RMB169.8 million, and its gross profit margin rose to 63.9%. Despite these gains, the board decided not to declare an interim dividend. The results highlight Yonghe’s strong market positioning and operational efficiency in the hair-related healthcare industry.
More about Yonghe Medical Group Co., Ltd.
Yonghe Medical Group Co., Ltd. is a leading medical group in China specializing in hair-related healthcare services. The company offers a comprehensive range of services including hair transplants, medical hair care, routine hair restoration, and ancillary services. It operates a network of 63 hair transplant clinics across 61 cities and six hair care centers under the Svenson brand, making it the largest hair-related healthcare clinic chain in China.
Average Trading Volume: 1,009,309
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.67B
Learn more about 2279 stock on TipRanks’ Stock Analysis page.